Literature DB >> 30972616

Patterns of onset and outcome of cryptogenic organizing pneumonia after allogeneic hematopoietic stem cell transplantation.

Yoshitaka Adachi1, Kazutaka Ozeki2, Shun Ukai2, Ken Sagou2, Nobuaki Fukushima2, Akio Kohno2.   

Abstract

Cryptogenic organizing pneumonia (COP) after allogeneic hematopoietic stem cell transplantation (HSCT) is characterized by frequent recurrence. Few studies have examined onset and recurrence patterns of COP after HSCT. We investigated the clinical features of COP after HSCT in a single-center retrospective study including 165 consecutive patients who underwent allogeneic HSCT. Eighteen patients (11%) developed COP after HSCT. Hypoxemia and pleural effusion at the onset of COP were significantly associated with umbilical cord blood transplantation (P = 0.002 and P = 0.002, respectively). Recurrence of COP was observed in six patients and significantly associated with the presence of chronic graft-versus-host disease (cGVHD; P = 0.013) and stem cell sources other than umbilical cord blood (P = 0.038). Four patients with COP died of pulmonary failure after recurrence of COP. No patients who underwent umbilical cord blood transplantation experienced recurrence of COP. These findings suggest that the clinical features at the onset of COP may depend on stem cell sources. Moreover, both stem cell source and the absence or presence of cGVHD may affect COP recurrence, indicating the need to develop treatment strategies against COP according to stem cell source and risk of cGVHD.

Entities:  

Keywords:  Allogeneic hematopoietic stem cell transplantation; Cryptogenic organizing pneumonia; Graft-versus-host disease; Recurrence; Umbilical cord blood transplantation

Mesh:

Year:  2019        PMID: 30972616     DOI: 10.1007/s12185-019-02643-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  3 in total

Review 1.  Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Authors:  Nevins W Todd; Sergei P Atamas; Stella E Hines; Irina G Luzina; Nirav G Shah; Edward J Britt; Andrew J Ghio; Jeffrey R Galvin
Journal:  Expert Rev Respir Med       Date:  2022-01-31       Impact factor: 3.772

2.  Significance of alveolar nitric oxide concentration in the airway of patients with organizing pneumonia after allogeneic hematopoietic stem cell transplantation.

Authors:  Yasuko Kajimura; Yukinori Nakamura; Tsunahiko Hirano; Yoshinori Tanaka; Kaoru Yamamoto; Yoshihiro Tokunaga; Takahiro Sasaki; Keiji Oishi; Toshiaki Yujiri; Kazuto Matsunaga; Yukio Tanizawa
Journal:  Ann Hematol       Date:  2022-05-23       Impact factor: 4.030

3.  Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation.

Authors:  Masaharu Tamaki; Shimpei Matsumi; Hideki Nakasone; Yuhei Nakamura; Masakatsu Kawamura; Shunto Kawamura; Junko Takeshita; Nozomu Yoshino; Yukiko Misaki; Kazuki Yoshimura; Ayumi Gomyo; Aki Tanihara; Yosuke Okada; Machiko Kusuda; Kazuaki Kameda; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  Bone Marrow Transplant       Date:  2022-06-04       Impact factor: 5.174

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.